THURSDAY MOVER: $OBMP OncBioMune Running On News Of Prostate Cancer Trial Completion
Final Patient Completes Treatment in OncBioMune Clinical Trial of ProscaVax for Prostate Cancer BATON ROUGE, LA–(Marketwired – August 24, 2017) – OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a revenue-stage biopharmaceutical company engaged in the development […]